MaPharma SRL
1.8 FTEMaPharma reported total assets of 256,730 € at the end of the 2024 financial year (annual accounts filed with the NBB on 01 May 2026), with 1.8 full-time equivalent.
The score of MaPharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MaPharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 01 May 2026
- Year ended 31 Dec 2023filed on 16 Apr 2025
MaPharma's financial analysis
- Solvency-40.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MaPharma
MaPharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0799.383.730
- VAT number
- BE0799383730
- Peppol
- Registered · 0208:0799383730 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 10 Mar 2023
- Registered office
- 6041 Charleroi
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2024 · filed on 01 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
MaPharma (SRL) has been based in Charleroi since 2023, active in: retail sale of pharmaceutical products. For 2024, it reports a net loss of 33,660 € and equity of −104,883 €; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -40.9%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to MaPharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Merelle Retail sale of pharmaceutical products Quévy · balance sheet 256,663 €
- Hesbiphar Retail sale of pharmaceutical products Hannut · balance sheet 255,869 €
- Medphar Retail sale of pharmaceutical products Schaerbeek · balance sheet 255,858 €
- Pharmadeville Retail sale of pharmaceutical products Bernissart · balance sheet 257,934 €
- Pharma VAL Retail sale of pharmaceutical products Profondeville · balance sheet 255,460 €
- Odepharma Retail sale of pharmaceutical products Koksijde · balance sheet 255,295 €
- Yasmin Libbrecht Retail sale of pharmaceutical products Antwerp · balance sheet 258,250 €
- Apotheek Van de Peer Sabine Retail sale of pharmaceutical products Edegem · balance sheet 258,424 €
Frequently asked questions about MaPharma
What is the revenue of MaPharma?
MaPharma files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of MaPharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0799383730 for MaPharma, if the company is VAT-registered. Its company number (CBE) is 0799.383.730.
Where is the registered office of MaPharma?
According to the CBE register, the registered office of MaPharma is in 6041 Charleroi.
What is the equity of MaPharma?
At the close of the 2024 financial year, the equity of MaPharma amounts to -104,883 €, a solvency of -40.9% of total assets.
How many people work at MaPharma?
1.8 full-time equivalents on average according to the 2024 social balance sheet.
Who manages MaPharma?
The register lists 1 active mandates at MaPharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MaPharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →